Screening for hepatocellular carcinoma in high-risk populations

Zoe A. Miller, Kyungmouk Steve Lee

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


Screening for hepatocellular carcinoma (HCC) should be implemented in the high-risk population. High-risk population includes patients with cirrhosis of any etiology, patients with chronic hepatitis B virus with or without cirrhosis, and patients with chronic hepatitis C virus with cirrhosis. A randomized controlled trial of over 18,000 high-risk individuals demonstrated that biannual screening reduced HCC-related mortality by 37%. The screening test of choice is ultrasound imaging with an interval of 6 months.

Original languageEnglish (US)
Pages (from-to)311-314
Number of pages4
JournalClinical Imaging
Issue number2
StatePublished - Mar 1 2016
Externally publishedYes


  • Cirrhosis
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular carcinoma screening
  • Liver cancer screening

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Screening for hepatocellular carcinoma in high-risk populations'. Together they form a unique fingerprint.

Cite this